Tehran University of Medical Sciences Journal of Pharmacoeconomics and Pharmaceutical Management 2383-4498 2 1/2 2017 07 10 45 49 Mehdi Varmaghani Department of Health Economics and Management Sciences, School of Health, Mashhad University of Medical Sciences, Mashhad AND Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Science Institute, Tehran University of Medical Sciences, Tehran, Iran Amir Hashemi-Meshkini Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Akbar Abdollahiasl Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Elham Heidari Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Science Institute, Tehran University of Medical Sciences, Tehran, Iran Hedieh-Sadat Zekri Department of Economics, School of Economics, Allameh-Tabatabaei University, Tehran, Iran Saeed Yaghoubifard Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran Farid Dorkoosh Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran 2017 07 09 2017 07 09 Pharmaceutical expenditure is a substantial part of the health-care system budget. In Iran, people are paying about half of total pharmaceutical expenditure out of their pocket. In this study, we reviewed the Iranian pharmaceuticals financing system including the current situation and the relevant policies. We also provide an overview about the new health-care system reform and its challenges ahead. https://jppm.tums.ac.ir/index.php/jppm/article/view/43 https://jppm.tums.ac.ir/index.php/jppm/article/download/43/25